Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
AstraZeneca
AZN
|
+$677M |
| 2 |
Tesla
TSLA
|
+$374M |
| 3 |
Constellation Brands
STZ
|
+$357M |
| 4 |
NVIDIA
NVDA
|
+$292M |
| 5 |
Meta Platforms (Facebook)
META
|
+$264M |
Top Sells
| 1 |
Netflix
NFLX
|
+$892M |
| 2 |
Charter Communications
CHTR
|
+$838M |
| 3 |
AbbVie
ABBV
|
+$553M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$488M |
| 5 |
FedEx
FDX
|
+$418M |
Sector Composition
| 1 | Technology | 21.08% |
| 2 | Consumer Discretionary | 17.73% |
| 3 | Financials | 13.26% |
| 4 | Healthcare | 11.95% |
| 5 | Communication Services | 11.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Oracle
ORCL
$893B
| $20.2M | 0.02% |
458,347
-339,521
| -43% | -$15M |
|
402
BioCryst Pharmaceuticals
BCRX
$1.69B
| $19.9M | 0.02% |
3,471,438
-33,157
| -0.9% | -$190K |
|
403
B&G Foods
BGS
$364M
| $19.9M | 0.02% |
665,042
+249,502
| +60% | +$7.46M |
|
404
Core Laboratories
CLB
$596M
| $19.8M | 0.02% |
156,534
-5,915
| -4% | -$747K |
|
405
Benchmark Electronics
BHE
$1.43B
| $19.7M | 0.02% |
677,498
-77,094
| -10% | -$2.25M |
|
406
BrightView Holdings
BV
$1.34B
| $19.6M | 0.02% |
+890,688
| New | +$19.6M |
|
|
MRNS
407
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $19.5M | 0.02% |
689,339
+5,433
| +0.8% | +$154K |
|
408
Freeport-McMoran
FCX
$65.5B
| $19.3M | 0.02% |
1,118,042
+296,228
| +36% | +$5.11M |
|
409
Kinder Morgan
KMI
$61.1B
| $19.2M | 0.02% |
1,088,031
+204,895
| +23% | +$3.62M |
|
410
Axogen
AXGN
$773M
| $18.9M | 0.02% |
375,636
+364,928
| +3,408% | +$18.3M |
|
|
VR
411
DELISTED
Validus Hold Ltd
VR
| $18.7M | 0.02% |
276,954
-242,707
| -47% | -$16.4M |
|
412
Independence Realty Trust
IRT
$4.14B
| $18.3M | 0.02% |
1,779,026
+50,155
| +3% | +$517K |
|
413
First Bancorp
FBNC
$2.28B
| $17.8M | 0.02% |
434,535
+24,066
| +6% | +$985K |
|
|
CONE
414
DELISTED
CyrusOne Inc Common Stock
CONE
| $17.7M | 0.02% |
304,025
-717,856
| -70% | -$41.9M |
|
415
Cardlytics
CDLX
$53.8M
| $17.5M | 0.02% |
806,281
-5,004
| -0.6% | -$109K |
|
|
FMI
416
DELISTED
Foundation Medicine, Inc.
FMI
| $17.3M | 0.02% |
126,761
+1,665
| +1% | +$228K |
|
417
Western Midstream Partners
WES
$14.6B
| $17.3M | 0.02% |
+483,943
| New | +$17.3M |
|
|
TSRO
418
DELISTED
TESARO, Inc.
TSRO
| $17.2M | 0.02% |
385,748
-3,837
| -1% | -$171K |
|
|
GSKY
419
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $16.9M | 0.02% |
+800,000
| New | +$16.9M |
|
420
Wingstop
WING
$7.7B
| $16.7M | 0.02% |
320,709
-159,655
| -33% | -$8.32M |
|
|
TCDA
421
DELISTED
Tricida, Inc. Common Stock
TCDA
| $16.7M | 0.02% |
+557,319
| New | +$16.7M |
|
422
Tenaris
TS
$18.7B
| $16.6M | 0.02% |
457,060
-186,536
| -29% | -$6.79M |
|
423
Fortinet
FTNT
$61.6B
| $16.5M | 0.02% |
1,325,305
-2,883,965
| -69% | -$36M |
|
424
Monolithic Power Systems
MPWR
$40.1B
| $16.4M | 0.02% |
122,827
-6,877
| -5% | -$919K |
|
425
Agios Pharmaceuticals
AGIO
$2.12B
| $16.3M | 0.02% |
193,935
+3,183
| +2% | +$268K |
|